Robert Blelloch, MD, PhD

Professor

Dr. Robert Blelloch received his MD and PhD degrees from the University of Wisconsin-Madison. While studying for his PhD under the mentorship of Judith Kimble, PhD he discovered a novel matrix metalloproteinase, which is essential for normal gonad morphogenesis in the C. elegans nematode. After earning his dual degree, Blelloch completed a residency in clinical pathology followed by a fellowship in transfusion medicine at Brigham and Women’s Hospital. During his residency and fellowship Blelloch concurrently conducted research at the Whitehead Institute of Biomedical Research under the mentorship of Rudolf Jaenisch, MD. Through this research, Blelloch developed an interest in the epigenetic regulation of normal development and disease. In particular, he used somatic cell nuclear transfer (SCNT) to globally evaluate the role of epigenetics in cancer. This approach enabled him to show a critical, although variable, role for epigenetics in tumor development and maintenance. He also used SCNT to show a role for global DNA methylation in the maintenance of cellular differentiation.

Since starting his own lab in 2006, Blelloch continues to follow his interest in the global regulators of cellular differentiation and cancer. His work is focused on the role of small noncoding RNAs in stem cell regulation and prostate cancer. Blelloch's ultimate goal is to develop a deeper understanding of the molecular underpinnings of normal and abnormal cell differentiation which will contribute to the advancement of regenerative medicine and cancer care.

Blelloch is a professor in three departments: Urology; Obstetrics, Gynecology and Reproductive Sciences; and Pathology. He holds the Peter R. Carroll, MD Endowed Chair in Urology. Blelloch is a member of the Eli and Edythe Broad Center of Regeneration Medicine and Stem Cell Research, the Center for Reproductive Sciences, and the UCSF Helen Diller Family Comprehensive Cancer Center. In 2013, Blelloch was named Associate Chair, Basic Science Research for the Department of Urology.

  • BS, 1989, Duke University, Durham, NC, Zoology
  • MAT, 1990, Duke University, Durham, NC, Biology
  • PhD, 1999, University of Wisconsin, Madison, WI, Cell & Molecular Biology
  • MD, 2001, University of Wisconsin, Madison, WI, Medicine
  • 2001-2004 Resident, Pathology, Brigham and Women's Hospital, Boston, MA
  • 2002-2005 Visiting Scientist, Whitehead Institute of Biomedical Research, Cambridge, MA
  • 2003-2003 Chief Resident, Pathology, Brigham and Women's Hospital, Boston, MA
  • 2004-2005 Fellow, Harvard Medical School Joint Program of Tranfusion Medcine, Boston, MA
  • 2005-2010 Assistant Professor, Department of Urology, University of California, San Francisco, CA
  • 2006-Present Peter R. Carroll, MD Endowed Chair, University of California, San Francisco, CA
  • 2010-2013 Associate Professor, Department of Urology, University of California, San Francisco, CA
  • 2013-Present, Vice Chair, Basic Science Research, Department of Urology
  • 2013-Present Professor, Department of Urology, University of California, San Francisco, CA

  • July 1, 1994 - April 30, 2030 - Predoctoral Training in Developmental Biology , Principal Investigator . Sponsor: NIH, Sponsor Award ID: T32HD007470
  • September 1, 2024 - August 31, 2029 - Evaluating and Optimizing Novel nSMase2 Inhibitors in the Treatment of Cancers , Principal Investigator . Sponsor: NIH, Sponsor Award ID: R01CA282475
  • September 23, 2019 - August 31, 2024 - Mechanisms of Exosome Driven Immunoregulation of Cancer Progression , Principal Investigator . Sponsor: NIH, Sponsor Award ID: U01CA244452
  • April 1, 2007 - March 31, 2024 - Center for Research, Innovation and Training in Reproduction and Infertility , Co-Investigator . Sponsor: NIH, Sponsor Award ID: P50HD055764
  • September 7, 2017 - July 31, 2021 - Rewiring of the pluripotency enhancer network during early mammalian development , Principal Investigator . Sponsor: NIH, Sponsor Award ID: R01GM122439
  • September 7, 2017 - July 31, 2021 - Iteratively redefining developmental potential through poised enhancers , Principal Investigator . Sponsor: NIH, Sponsor Award ID: R01GM125089
  • August 15, 2017 - July 31, 2020 - Emergence of divergent cell cycle programs during mammalian development , Principal Investigator . Sponsor: NIH, Sponsor Award ID: R21HD093084
  • September 1, 2013 - August 31, 2019 - In Vivo Regulated Release and Function of Extracellular Small RNAs , Principal Investigator . Sponsor: NIH, Sponsor Award ID: U19CA179512
  • May 1, 2012 - April 30, 2017 - MicroRNA Based Pathway Discovery in Cellular Reprogramming , Principal Investigator . Sponsor: NIH, Sponsor Award ID: R01GM101180
  • May 3, 2007 - March 31, 2017 - Origins and Biological Consequences of Human Infertility , Co-Investigator . Sponsor: NIH, Sponsor Award ID: U54HD055764
  • September 1, 2011 - August 31, 2015 - MiRNAs as prognostic markers for prostate cancer patients on active surveillance , Principal Investigator . Sponsor: NIH, Sponsor Award ID: R21CA161615
  • June 1, 1975 - April 30, 2015 - California National Primate Research Center , Co-Investigator . Sponsor: NIH, Sponsor Award ID: P51RR000169
  • June 15, 2007 - May 31, 2014 - Small RNAs in Stem Cell Differentiation and Neural Development , Principal Investigator . Sponsor: NIH, Sponsor Award ID: R01NS057221
  • July 1, 2005 - February 29, 2012 - Determinants of Neural &Embryonic Stem Cell Potency , Principal Investigator . Sponsor: NIH, Sponsor Award ID: K08NS048118